HOUSE 2706117th CongressReferred to the Subcommittee on Health.
Freedom from Price Gouging Act
- Last Action
- 4/21/2021
Actions
- 2021-04-21Referred to the Subcommittee on Health.
- 2021-04-20Referred to the Subcommittee on Social Security.
- 2021-04-20Referred to the Subcommittee on Health.
- 2021-04-20Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2021-04-20Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2021-04-20Introduced in House
- 2021-04-20Introduced in House
CRS Summary
As of 2021-04-20 (00)
Freedom from Price Gouging Act
This bill requires drug manufacturers to issue rebates to the Centers for Medicare & Medicaid Services for covered drugs under Medicare that cost $100 or more and for which the average manufacturer price increases faster than inflation.
Cosponsors (4)
- Lauren Underwood (D-IL)
- Jason Crow (D-CO)
- EARL BLUMENAUER (D-OR)
- Mondaire Jones (D-NY)
Subjects
- Civil actions and liability
- Congressional oversight
- Government studies and investigations
- Health care costs and insurance
- Inflation and prices
- Medicare
- Prescription drugs
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.